• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

安全补液预防肾功能不全合并心力衰竭患者在接受冠状动脉造影或经皮冠状动脉介入治疗时发生造影剂诱导的急性肾损伤及心力衰竭恶化

Safe Hydration to Prevent Contrast-Induced Acute Kidney Injury and Worsening Heart Failure in Patients with Renal Insufficiency and Heart Failure Undergoing Coronary Angiography or Percutaneous Coronary Intervention.

作者信息

Bei Wei-Jie, Wang Kun, Li Hua-Long, Guo Xiao-Sheng, Guo Wei, Abuduaini Tuerxunjiang, Chen Shi-Qun, Islam Sheikh Mohammed Shariful, Chen Peng-Yuan, Chen Ji-Yan, Liu Yong, Tan Ning

机构信息

Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Key Laboratory of Coronary Disease, Guangdong General Hospital, Guangdong Academy of Medical Sciences.

School of Medicine, South China University of Technology.

出版信息

Int Heart J. 2019 Mar 20;60(2):247-254. doi: 10.1536/ihj.17-066. Epub 2019 Feb 22.

DOI:10.1536/ihj.17-066
PMID:30799374
Abstract

An optimal hydration volume (HV) that prevents contrast-induced acute kidney injury (CI-AKI) in patients with renal insufficiency and heart failure (HF) at a high risk of worsening HF (WHF) has not been determined. We aimed to determine a safe HV that prevents CI-AKI and WHF following coronary angiography (CAG) or percutaneous coronary intervention (PCI) in patients with renal insufficiency and HF. We recruited 1,307 patients with renal insufficiency and HF and investigated the relationships between the peri-procedural HV/weight (HV/W) ratio, and the risks of CI-AKI and WHF following CAG or PCI. Higher HV/W quartiles were associated with higher CI-AKI rates (Q1: 6.2%, Q2: 9.1%, Q3: 12.5%, and Q4: 18.7%; P < 0.001) and a greater likelihood of WHF (Q1: 2.2%, Q2: 2.7%, Q3: 4.9%, and Q4: 11.7%; P < 0.001). The multivariate analyses indicated that excessively high HV/W ratios were associated with moderately increased risks of CI-AKI (Q4 versus Q1: adjusted odds ratio [OR] 2.16, 95% confidence interval [CI] 1.17-4.00) and WHF (Q4 versus Q1: adjusted OR 3.09, 95% CI 1.21-7.88). The multivariate Cox regression analysis indicated that a higher HV/W ratio was associated with significantly increased long-term mortality (Q2 versus Q1: adjusted hazard ratio [HR] 2.36; Q3 versus Q1: adjusted HR 2.85; Q4 versus Q1: adjusted HR 2.94; all P < 0.05). In conclusion, an excessively high HV/W might be associated with a moderately increased risk of CI-AKI, WHF, and long-term mortality in patients with renal insufficiency and HF.

摘要

尚未确定能预防肾功能不全和心力衰竭(HF)且有HF恶化高风险(WHF)患者发生造影剂诱导的急性肾损伤(CI-AKI)的最佳水化量(HV)。我们旨在确定一个安全的HV,以预防肾功能不全和HF患者在冠状动脉造影(CAG)或经皮冠状动脉介入治疗(PCI)后发生CI-AKI和WHF。我们招募了1307例肾功能不全和HF患者,并研究了围手术期HV/体重(HV/W)比值与CAG或PCI后CI-AKI和WHF风险之间的关系。较高的HV/W四分位数与较高的CI-AKI发生率相关(第一四分位数:6.2%,第二四分位数:9.1%,第三四分位数:12.5%,第四四分位数:18.7%;P<0.001)以及WHF的可能性更大(第一四分位数:2.2%,第二四分位数:2.7%,第三四分位数:4.9%,第四四分位数:11.7%;P<0.001)。多变量分析表明,过高的HV/W比值与CI-AKI风险适度增加相关(第四四分位数与第一四分位数相比:调整后的优势比[OR]2.16,95%置信区间[CI]1.17-4.00)和WHF(第四四分位数与第一四分位数相比:调整后的OR 3.09,95%CI 1.21-7.88)。多变量Cox回归分析表明,较高的HV/W比值与长期死亡率显著增加相关(第二四分位数与第一四分位数相比:调整后的风险比[HR]2.36;第三四分位数与第一四分位数相比:调整后的HR 2.85;第四四分位数与第一四分位数相比:调整后的HR 2.94;所有P<0.05)。总之,过高的HV/W可能与肾功能不全和HF患者发生CI-AKI、WHF和长期死亡率的风险适度增加相关。

相似文献

1
Safe Hydration to Prevent Contrast-Induced Acute Kidney Injury and Worsening Heart Failure in Patients with Renal Insufficiency and Heart Failure Undergoing Coronary Angiography or Percutaneous Coronary Intervention.安全补液预防肾功能不全合并心力衰竭患者在接受冠状动脉造影或经皮冠状动脉介入治疗时发生造影剂诱导的急性肾损伤及心力衰竭恶化
Int Heart J. 2019 Mar 20;60(2):247-254. doi: 10.1536/ihj.17-066. Epub 2019 Feb 22.
2
Safe Hydration Volume to Prevent Contrast-induced Acute Kidney Injury and Worsening Heart Failure in Patients With Heart Failure and Preserved Ejection Fraction After Cardiac Catheterization.安全补液量以预防心力衰竭和射血分数保留的经导管心内检查后的心力衰竭患者的造影剂相关急性肾损伤和心力衰竭恶化。
J Cardiovasc Pharmacol. 2017 Sep;70(3):168-175. doi: 10.1097/FJC.0000000000000502.
3
Excessively High Hydration Volume May Not Be Associated With Decreased Risk of Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention in Patients With Renal Insufficiency.对于肾功能不全患者,经皮冠状动脉介入治疗后,过高的水化量可能与对比剂诱导的急性肾损伤风险降低无关。
J Am Heart Assoc. 2016 May 27;5(6):e003171. doi: 10.1161/JAHA.115.003171.
4
Association between prophylactic hydration volume and risk of contrast-induced nephropathy after emergent percutaneous coronary intervention.急诊经皮冠状动脉介入治疗后预防性补液量与对比剂肾病风险之间的关联。
Cardiol J. 2017;24(6):660-670. doi: 10.5603/CJ.a2017.0048. Epub 2017 Apr 10.
5
Optimal hydration volume among high-risk patients with advanced congestive heart failure undergoing coronary angiography.接受冠状动脉造影的晚期充血性心力衰竭高危患者的最佳补液量
Oncotarget. 2018 May 4;9(34):23738-23748. doi: 10.18632/oncotarget.25315.
6
HDL Cholesterol Level Is Associated with Contrast Induced Acute Kidney Injury in Chronic Kidney Disease Patients Undergoing PCI.高密度脂蛋白胆固醇水平与接受经皮冠状动脉介入治疗的慢性肾脏病患者的造影剂诱导急性肾损伤相关。
Sci Rep. 2016 Oct 24;6:35774. doi: 10.1038/srep35774.
7
Predictors of outcomes of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with chronic kidney disease.慢性肾脏病患者经皮冠状动脉介入治疗后对比剂诱导的急性肾损伤结局的预测因素
Am J Cardiol. 2014 Dec 15;114(12):1830-5. doi: 10.1016/j.amjcard.2014.09.022. Epub 2014 Sep 28.
8
Hyperuricemia Is an Independent Predictor of Contrast-Induced Acute Kidney Injury and Mortality in Patients Undergoing Percutaneous Coronary Intervention.高尿酸血症是接受经皮冠状动脉介入治疗患者发生造影剂诱导的急性肾损伤和死亡的独立预测因素。
Angiology. 2015 Sep;66(8):721-6. doi: 10.1177/0003319714568516. Epub 2015 Jan 23.
9
LDL cholesterol as a novel risk factor for contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention.低密度脂蛋白胆固醇作为接受经皮冠状动脉介入治疗患者发生对比剂诱导急性肾损伤的一种新的危险因素。
Atherosclerosis. 2014 Dec;237(2):453-9. doi: 10.1016/j.atherosclerosis.2014.10.022. Epub 2014 Oct 17.
10
Variation in contrast-associated acute kidney injury prophylaxis for percutaneous coronary intervention: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) program.经皮冠状动脉介入治疗中对比剂相关急性肾损伤预防的变化:来自退伍军人事务临床评估、报告和跟踪(CART)计划的见解。
BMC Nephrol. 2020 Apr 28;21(1):150. doi: 10.1186/s12882-020-01802-z.

引用本文的文献

1
Investigating the Prevalence of Contrast-associated Nephropathy and the Related Risk Factors in Patients Undergoing Elective Angioplasty.调查择期血管成形术患者中对比剂相关性肾病的患病率及相关危险因素。
J Res Pharm Pract. 2024 Jan 31;12(2):64-67. doi: 10.4103/jrpp.jrpp_1_24. eCollection 2023 Apr-Jun.
2
Volume Status, a Novel Marker of Contrast Induced Acute Kidney Injury in Acute Heart Failure Undergoing Coronary Angiography?容量状态,冠状动脉造影急性心力衰竭患者中造影剂诱发急性肾损伤的新标志物?
Int J Heart Fail. 2020 Jan 20;2(1):69-71. doi: 10.36628/ijhf.2019.0018. eCollection 2020 Jan.
3
Predictive value of plasma volume status for contrast-induced nephropathy in patients with heart failure undergoing PCI.
心力衰竭患者行经皮冠状动脉介入治疗时,血容量状态对造影剂肾病的预测价值。
ESC Heart Fail. 2021 Dec;8(6):4873-4881. doi: 10.1002/ehf2.13681. Epub 2021 Oct 26.
4
Association of the classification and severity of heart failure with the incidence of contrast-induced acute kidney injury.心力衰竭的分类和严重程度与对比剂诱导的急性肾损伤的发生率之间的关联。
Sci Rep. 2021 Jul 28;11(1):15348. doi: 10.1038/s41598-021-94910-1.
5
Efficacy and safety of intracoronary prourokinase during percutaneous coronary intervention in treating ST-segment elevation myocardial infarction patients: a randomized, controlled study.经皮冠状动脉介入治疗 ST 段抬高型心肌梗死患者中冠状动脉内应用尿激酶原的疗效及安全性:一项随机对照研究。
BMC Cardiovasc Disord. 2020 Jun 26;20(1):308. doi: 10.1186/s12872-020-01584-0.